Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Is there an association between socioeconomic status and immune response to infant and childhood vaccination in the Netherlands?

van den Boogaard J, Rots NY, van der Klis F, de Melker HE, Knol MJ.

Vaccine. 2020 Feb 13. pii: S0264-410X(20)30113-4. doi: 10.1016/j.vaccine.2020.01.071. [Epub ahead of print]

PMID:
32063433
2.

Persisting Antibody Response Nine Years after Bivalent HPV Vaccination in A Cohort of Dutch Women: Immune Response and the Relation with Genital HPV Infections.

Hoes J, Pasmans H, Knol MJ, Donken R, van Marm-Wattimena N, Schepp RM, King AJ, van der Klis FRM, de Melker HE.

J Infect Dis. 2020 Jan 9. pii: jiaa007. doi: 10.1093/infdis/jiaa007. [Epub ahead of print]

PMID:
31917429
3.

Genetic architecture of subcortical brain structures in 38,851 individuals.

Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, Teumer A, van der Lee SJ, Yang J, Yanek LR, Lee TV, Li S, Hu Y, Koh JY, Eicher JD, Desrivières S, Arias-Vasquez A, Chauhan G, Athanasiu L, Rentería ME, Kim S, Hoehn D, Armstrong NJ, Chen Q, Holmes AJ, den Braber A, Kloszewska I, Andersson M, Espeseth T, Grimm O, Abramovic L, Alhusaini S, Milaneschi Y, Papmeyer M, Axelsson T, Ehrlich S, Roiz-Santiañez R, Kraemer B, Håberg AK, Jones HJ, Pike GB, Stein DJ, Stevens A, Bralten J, Vernooij MW, Harris TB, Filippi I, Witte AV, Guadalupe T, Wittfeld K, Mosley TH, Becker JT, Doan NT, Hagenaars SP, Saba Y, Cuellar-Partida G, Amin N, Hilal S, Nho K, Mirza-Schreiber N, Arfanakis K, Becker DM, Ames D, Goldman AL, Lee PH, Boomsma DI, Lovestone S, Giddaluru S, Le Hellard S, Mattheisen M, Bohlken MM, Kasperaviciute D, Schmaal L, Lawrie SM, Agartz I, Walton E, Tordesillas-Gutierrez D, Davies GE, Shin J, Ipser JC, Vinke LN, Hoogman M, Jia T, Burkhardt R, Klein M, Crivello F, Janowitz D, Carmichael O, Haukvik UK, Aribisala BS, Schmidt H, Strike LT, Cheng CY, Risacher SL, Pütz B, Fleischman DA, Assareh AA, Mattay VS, Buckner RL, Mecocci P, Dale AM, Cichon S, Boks MP, Matarin M, Penninx BWJH, Calhoun VD, Chakravarty MM, Marquand AF, Macare C, Kharabian Masouleh S, Oosterlaan J, Amouyel P, Hegenscheid K, Rotter JI, Schork AJ, Liewald DCM, de Zubicaray GI, Wong TY, Shen L, Sämann PG, Brodaty H, Roffman JL, de Geus EJC, Tsolaki M, Erk S, van Eijk KR, Cavalleri GL, van der Wee NJA, McIntosh AM, Gollub RL, Bulayeva KB, Bernard M, Richards JS, Himali JJ, Loeffler M, Rommelse N, Hoffmann W, Westlye LT, Valdés Hernández MC, Hansell NK, van Erp TGM, Wolf C, Kwok JBJ, Vellas B, Heinz A, Olde Loohuis LM, Delanty N, Ho BC, Ching CRK, Shumskaya E, Singh B, Hofman A, van der Meer D, Homuth G, Psaty BM, Bastin ME, Montgomery GW, Foroud TM, Reppermund S, Hottenga JJ, Simmons A, Meyer-Lindenberg A, Cahn W, Whelan CD, van Donkelaar MMJ, Yang Q, Hosten N, Green RC, Thalamuthu A, Mohnke S, Hulshoff Pol HE, Lin H, Jack CR Jr, Schofield PR, Mühleisen TW, Maillard P, Potkin SG, Wen W, Fletcher E, Toga AW, Gruber O, Huentelman M, Davey Smith G, Launer LJ, Nyberg L, Jönsson EG, Crespo-Facorro B, Koen N, Greve DN, Uitterlinden AG, Weinberger DR, Steen VM, Fedko IO, Groenewold NA, Niessen WJ, Toro R, Tzourio C, Longstreth WT Jr, Ikram MK, Smoller JW, van Tol MJ, Sussmann JE, Paus T, Lemaître H, Schroeter ML, Mazoyer B, Andreassen OA, Holsboer F, Depondt C, Veltman DJ, Turner JA, Pausova Z, Schumann G, van Rooij D, Djurovic S, Deary IJ, McMahon KL, Müller-Myhsok B, Brouwer RM, Soininen H, Pandolfo M, Wassink TH, Cheung JW, Wolfers T, Martinot JL, Zwiers MP, Nauck M, Melle I, Martin NG, Kanai R, Westman E, Kahn RS, Sisodiya SM, White T, Saremi A, van Bokhoven H, Brunner HG, Völzke H, Wright MJ, van 't Ent D, Nöthen MM, Ophoff RA, Buitelaar JK, Fernández G, Sachdev PS, Rietschel M, van Haren NEM, Fisher SE, Beiser AS, Francks C, Saykin AJ, Mather KA, Romanczuk-Seiferth N, Hartman CA, DeStefano AL, Heslenfeld DJ, Weiner MW, Walter H, Hoekstra PJ, Nyquist PA, Franke B, Bennett DA, Grabe HJ, Johnson AD, Chen C, van Duijn CM, Lopez OL, Fornage M, Wardlaw JM, Schmidt R, DeCarli C, De Jager PL, Villringer A, Debette S, Gudnason V, Medland SE, Shulman JM, Thompson PM, Seshadri S, Ikram MA.

Nat Genet. 2019 Nov;51(11):1624-1636. doi: 10.1038/s41588-019-0511-y. Epub 2019 Oct 21.

PMID:
31636452
4.

Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.

Garcia Garrido HM, Mak AMR, Wit FWNM, Wong GWM, Knol MJ, Vollaard A, Tanck MWT, Van Der Ende A, Grobusch MP, Goorhuis A.

Clin Infect Dis. 2019 Oct 21. pii: ciz728. doi: 10.1093/cid/ciz728. [Epub ahead of print]

PMID:
31634398
5.

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004-2016.

Brandwagt DAH, van der Ende A, Ruijs WLM, de Melker HE, Knol MJ.

BMC Infect Dis. 2019 Oct 17;19(1):860. doi: 10.1186/s12879-019-4513-2.

6.

Gray Matter Age Prediction as a Biomarker for Risk of Dementia.

Wang J, Knol MJ, Tiulpin A, Dubost F, de Bruijne M, Vernooij MW, Adams HHH, Ikram MA, Niessen WJ, Roshchupkin GV.

Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21213-21218. doi: 10.1073/pnas.1902376116. Epub 2019 Oct 1.

PMID:
31575746
7.

Migraine Genetic Variants Influence Cerebral Blood Flow.

Knol MJ, Loehrer EA, Wen KX, Bos D, Ikram MK, Vernooij MW, Adams HHH, Ikram MA.

Headache. 2020 Jan;60(1):90-100. doi: 10.1111/head.13651. Epub 2019 Sep 26.

8.

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015-2018.

Loenenbach AD, van der Ende A, de Melker HE, Sanders EAM, Knol MJ.

Clin Infect Dis. 2019 Sep 26. pii: ciz578. doi: 10.1093/cid/ciz578. [Epub ahead of print]

PMID:
31556938
9.

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.

Vestjens SMT, Sanders EAM, Vlaminckx BJ, de Melker HE, van der Ende A, Knol MJ.

Vaccine. 2019 Oct 8;37(43):6558-6565. doi: 10.1016/j.vaccine.2019.08.025. Epub 2019 Sep 6.

PMID:
31500963
10.

A genome-wide association study identifies genetic loci associated with specific lobar brain volumes.

van der Lee SJ, Knol MJ, Chauhan G, Satizabal CL, Smith AV, Hofer E, Bis JC, Hibar DP, Hilal S, van den Akker EB, Arfanakis K, Bernard M, Yanek LR, Amin N, Crivello F, Cheung JW, Harris TB, Saba Y, Lopez OL, Li S, van der Grond J, Yu L, Paus T, Roshchupkin GV, Amouyel P, Jahanshad N, Taylor KD, Yang Q, Mathias RA, Boehringer S, Mazoyer B, Rice K, Cheng CY, Maillard P, van Heemst D, Wong TY, Niessen WJ, Beiser AS, Beekman M, Zhao W, Nyquist PA, Chen C, Launer LJ, Psaty BM, Ikram MK, Vernooij MW, Schmidt H, Pausova Z, Becker DM, De Jager PL, Thompson PM, van Duijn CM, Bennett DA, Slagboom PE, Schmidt R, Longstreth WT, Ikram MA, Seshadri S, Debette S, Gudnason V, Adams HHH, DeCarli C.

Commun Biol. 2019 Aug 2;2:285. doi: 10.1038/s42003-019-0537-9. eCollection 2019.

11.

Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands.

Hoes J, Knol MJ, Mollema L, Buisman A, de Melker HE, van der Klis FRM.

Vaccine. 2019 Jul 26;37(32):4504-4510. doi: 10.1016/j.vaccine.2019.06.055. Epub 2019 Jul 4.

PMID:
31279563
12.

Corticosteroids and Regional Variations in Thickness of the Human Cerebral Cortex across the Lifespan.

Parker N, Vidal-Pineiro D, French L, Shin J, Adams HHH, Brodaty H, Cox SR, Deary IJ, Fjell AM, Frenzel S, Grabe H, Hosten N, Ikram MA, Jiang J, Knol MJ, Mazoyer B, Mishra A, Sachdev PS, Salum G, Satizabal CL, Schmidt H, Schmidt R, Seshadri S, Schumann G, Völzke H, Walhovd KB, Wen W, Wittfeld K, Yang Q, Debette S, Pausova Z, Paus T.

Cereb Cortex. 2019 Jun 26. pii: bhz108. doi: 10.1093/cercor/bhz108. [Epub ahead of print]

PMID:
31240317
13.

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.

Krone M, Gray S, Abad R, Skoczyńska A, Stefanelli P, van der Ende A, Tzanakaki G, Mölling P, João Simões M, Křížová P, Emonet S, Caugant DA, Toropainen M, Vazquez J, Waśko I, Knol MJ, Jacobsson S, Rodrigues Bettencourt C, Musilek M, Born R, Vogel U, Borrow R.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800245.

14.

Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis.

van den Berg SPH, Warmink K, Borghans JAM, Knol MJ, van Baarle D.

Med Microbiol Immunol. 2019 Aug;208(3-4):305-321. doi: 10.1007/s00430-019-00602-z. Epub 2019 Apr 4.

15.

Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.

Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY.

Lancet Infect Dis. 2019 Apr;19(4):392-401. doi: 10.1016/S1473-3099(18)30717-5. Epub 2019 Mar 27.

PMID:
30938299
16.

Genetic variation underlying cognition and its relation with neurological outcomes and brain imaging.

Knol MJ, Heshmatollah A, Cremers LGM, Ikram MK, Uitterlinden AG, van Duijn CM, Niessen WJ, Vernooij MW, Ikram MA, Adams HHH.

Aging (Albany NY). 2019 Mar 4;11(5):1440-1456. doi: 10.18632/aging.101844.

17.

Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.

van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY.

Vaccines (Basel). 2018 Dec 11;6(4). pii: E82. doi: 10.3390/vaccines6040082.

18.

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.

Hoes J, Boef AGC, Knol MJ, de Melker HE, Mollema L, van der Klis FRM, Rots NY, van Baarle D.

Front Public Health. 2018 Jul 27;6:209. doi: 10.3389/fpubh.2018.00209. eCollection 2018.

19.

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

Donken R, Tami A, Knol MJ, Lubbers K, van der Sande MAB, Nijman HW, Daemen T, Weijmar Schultz WCM, de Melker HE.

BMC Public Health. 2018 Jul 5;18(1):837. doi: 10.1186/s12889-018-5745-6.

20.

The Contribution of Genetic Variation of Streptococcus pneumoniae to the Clinical Manifestation of Invasive Pneumococcal Disease.

Cremers AJH, Mobegi FM, van der Gaast-de Jongh C, van Weert M, van Opzeeland FJ, Vehkala M, Knol MJ, Bootsma HJ, Välimäki N, Croucher NJ, Meis JF, Bentley S, van Hijum SAFT, Corander J, Zomer AL, Ferwerda G, de Jonge MI.

Clin Infect Dis. 2019 Jan 1;68(1):61-69. doi: 10.1093/cid/ciy417.

PMID:
29788414
21.

Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study.

Monge S, Hahné SJ, de Melker HE, Sanders EA, van der Ende A, Knol MJ.

Lancet Infect Dis. 2018 Jul;18(7):749-757. doi: 10.1016/S1473-3099(18)30166-X. Epub 2018 May 8.

PMID:
29752131
22.

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018.

Knol MJ, Ruijs WL, Antonise-Kamp L, de Melker HE, van der Ende A.

Euro Surveill. 2018 Apr;23(16). doi: 10.2807/1560-7917.ES.2018.23.16.18-00158.

23.

Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.

Vissers M, Wijmenga-Monsuur AJ, Knol MJ, Badoux P, van Houten MA, van der Ende A, Sanders EAM, Rots NY.

PLoS One. 2018 Mar 30;13(3):e0194823. doi: 10.1371/journal.pone.0194823. eCollection 2018.

24.

Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction.

Rietbergen C, Stefansdottir G, Leufkens HG, Knol MJ, De Bruin ML, Klugkist I.

Front Med (Lausanne). 2018 Feb 22;4:228. doi: 10.3389/fmed.2017.00228. eCollection 2017.

25.

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.

Knol MJ, Hahné SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, Borrow R, Ladhani SN, Ramsay ME, van der Ende A.

Lancet Public Health. 2017 Oct;2(10):e473-e482. doi: 10.1016/S2468-2667(17)30157-3. Epub 2017 Aug 24.

26.

Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.

Boef AGC, van der Klis FRM, Berbers GAM, Buisman AM, Sanders EAM, Kemmeren JM, van der Ende A, de Melker HE, Rots NY, Knol MJ.

Vaccine. 2018 Jan 8;36(3):400-407. doi: 10.1016/j.vaccine.2017.11.070. Epub 2017 Dec 6.

PMID:
29223483
27.

Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.

van Deursen AMM, Schurink-Van't Klooster TM, Man WH, van de Kassteele J, van Gageldonk-Lafeber AB, Bruijning-Verhagen PCJL, de Melker HE, Sanders EAM, Knol MJ.

Vaccine. 2017 Dec 18;35(51):7107-7113. doi: 10.1016/j.vaccine.2017.10.090. Epub 2017 Nov 13.

PMID:
29146381
28.

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.

Tielemans SMAJ, de Melker HE, Hahné SJM, Boef AGC, van der Klis FRM, Sanders EAM, van der Sande MAB, Knol MJ.

BMJ. 2017 Aug 30;358:j3862. doi: 10.1136/bmj.j3862.

29.

[Gastrointestinal symptoms with meningococcal infection. Emergence of Neisseria meningitidis serogroup W.]

Wunderink HF, Vlasveld IN, Knol MJ, van der Ende A, van Essen EHR, Kuijper EJ.

Ned Tijdschr Geneeskd. 2017;161:D1456. Dutch.

PMID:
28745253
30.

Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM.

Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28.

PMID:
28668575
31.

Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017.

Russcher A, Fanoy E, van Olden GDJ, Graafland AD, van der Ende A, Knol MJ.

Euro Surveill. 2017 Jun 8;22(23). pii: 30549. doi: 10.2807/1560-7917.ES.2017.22.23.30549.

32.

Dutch national immunization schedule: compliance and associated characteristics for the primary series.

Scheepers ED, van Lier A, Drijfhout IH, Berbers G, van der Maas NAT, de Melker HE, Knol MJ.

Eur J Pediatr. 2017 Jun;176(6):769-778. doi: 10.1007/s00431-017-2904-1. Epub 2017 Apr 20.

PMID:
28429116
33.

ECDC Round Table Report and ProMed-mail most useful international information sources for the Netherlands Early Warning Committee.

Bijkerk P, Monnier AA, Fanoy EB, Kardamanidis K, Friesema IH, Knol MJ.

Euro Surveill. 2017 Apr 6;22(14). pii: 30502. doi: 10.2807/1560-7917.ES.2017.22.14.30502.

34.

Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study.

Woudenberg T, van der Maas NAT, Knol MJ, de Melker H, van Binnendijk RS, Hahné SJM.

J Infect Dis. 2017 Apr 15;215(8):1181-1187. doi: 10.1093/infdis/jiw586.

PMID:
28368471
35.

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.

van Nieuwkoop C, van der Starre WE, Stalenhoef JE, van Aartrijk AM, van der Reijden TJ, Vollaard AM, Delfos NM, van 't Wout JW, Blom JW, Spelt IC, Leyten EM, Koster T, Ablij HC, van der Beek MT, Knol MJ, van Dissel JT.

BMC Med. 2017 Apr 3;15(1):70. doi: 10.1186/s12916-017-0835-3.

36.

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.

Wagenvoort GH, Sanders EA, Vlaminckx BJ, de Melker HE, van der Ende A, Knol MJ.

Euro Surveill. 2017 Mar 9;22(10). pii: 30481. doi: 10.2807/1560-7917.ES.2017.22.10.30481.

37.

Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia.

Wagenvoort GH, Sanders EA, de Melker HE, van der Ende A, Vlaminckx BJ, Knol MJ.

Vaccine. 2017 Mar 27;35(14):1749-1757. doi: 10.1016/j.vaccine.2017.02.037. Epub 2017 Mar 3.

PMID:
28262334
38.

Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls.

Donken R, Schurink-Van't Klooster TM, Schepp RM, van der Klis FR, Knol MJ, Meijer CJ, de Melker HE.

J Infect Dis. 2017 Feb 1;215(3):359-367. doi: 10.1093/infdis/jiw588.

PMID:
28011916
39.

Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2016 May 11;11(5):e0155088. doi: 10.1371/journal.pone.0155088. eCollection 2016.

40.

Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.

Prins-van Ginkel AC, Berbers GA, Grundeken LH, Tcherniaeva I, Wittenberns JI, Elberse K, Mollema L, de Melker HE, Knol MJ.

PLoS One. 2016 Jan 21;11(1):e0147437. doi: 10.1371/journal.pone.0147437. eCollection 2016.

41.

Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.

Wagenvoort GH, Sanders EA, Vlaminckx BJ, Elberse KE, de Melker HE, van der Ende A, Knol MJ.

Vaccine. 2016 Feb 17;34(8):1077-85. doi: 10.1016/j.vaccine.2015.12.066. Epub 2016 Jan 8.

PMID:
26778420
42.

Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes.

Elberse KE, Wagenvoort GH, Pluister GN, de Melker HE, Sanders EA, van der Ende A, Knol MJ.

Future Microbiol. 2016;11(1):31-41. doi: 10.2217/fmb.15.119. Epub 2015 Dec 17.

PMID:
26673757
43.

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015. Erratum in: PLoS One. 2016;11(5):e0155088.

44.

Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands.

Wagenvoort GH, Knol MJ, de Melker HE, Vlaminckx BJ, van der Ende A, Rozenbaum MH, Sanders EA.

Vaccine. 2016 Jan 12;34(3):334-40. doi: 10.1016/j.vaccine.2015.11.048. Epub 2015 Nov 29.

PMID:
26647289
45.

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands.

Knol MJ, Wagenvoort GH, Sanders EA, Elberse K, Vlaminckx BJ, de Melker HE, van der Ende A.

Emerg Infect Dis. 2015 Nov;21(11):2040-4. doi: 10.3201/eid2111.140780. Erratum in: Emerg Infect Dis. 2016 Jan;22(1):161. Emerg Infect Dis. 2016 Jan;22(1):161.

46.

Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.

Stoof SP, Rodenburg GD, Knol MJ, Rümke LW, Bovenkerk S, Berbers GA, Spanjaard L, van der Ende A, Sanders EA.

Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.

PMID:
26123933
47.

Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study.

Mollers M, King AJ, Knol MJ, Scherpenisse M, Meijer CJ, van der Klis FR, de Melker HE.

Vaccine. 2015 May 28;33(23):2678-83. doi: 10.1016/j.vaccine.2015.04.016. Epub 2015 Apr 14.

PMID:
25887090
48.

Gender-specific mortality in DTP-IPV- and MMR±MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study.

Schurink-van't Klooster TM, Knol MJ, de Melker HE, van der Sande MA.

BMC Infect Dis. 2015 Mar 24;15:148. doi: 10.1186/s12879-015-0898-8.

49.

Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

van Westen E, Wijmenga-Monsuur AJ, van Dijken HH, van Gaans-van den Brink JA, Kuipers B, Knol MJ, Berbers GA, Sanders EA, Rots NY, van Els CA.

Clin Infect Dis. 2015 Aug 1;61(3):342-9. doi: 10.1093/cid/civ274. Epub 2015 Apr 1.

50.

Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.

Donken R, Knol MJ, Bogaards JA, van der Klis FR, Meijer CJ, de Melker HE.

J Infect. 2015 Jul;71(1):61-73. doi: 10.1016/j.jinf.2015.02.005. Epub 2015 Feb 21. Review.

PMID:
25709084

Supplemental Content

Loading ...
Support Center